OCC Trading, page-742

You know my view. It will likely get partnered in ATI by J&J. If not, someone else will come and snap it up once it has the holy grail of randomised controlled trial data. Its a pre-requisite now for bio-tech R&D given Fauci's popularisation. There are actually plenty of circumstances, like trials in kids, when RCT's are not ethical. Its got that silly, a Surgeon friend of mine sits on an ethics reviww board that now passes sham surgery RCT's. Such have they become the demanded blind pre-requisite, that its now morally okay to give sham surgeries to poor suffering souls for the greater good, because we can't accept past study cohorts.

I digress, with human RCT data onboard, OCC's ATI will be infinitely more sellable. Such a shame the hundreds of satisfied patients over the last decade count for little.